Clinical Trial Update: Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand [Phase 2]

View source ↗

Summary

Phase 2 trial update on intraoperative detection of occult ovarian cancer using a folate-receptor targeted fluorescent ligand; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• folate-alpha receptor specific fluorescent ligand

Snippet

Sponsor: Mayo Clinic | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-10-14